BlackRock Institutional Trust’s Global Blood Therapeutics, Inc. GBT Stock Holding History

BlackRock Institutional Trust’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7.75M	Buy	536,582 +222,091	+71%	+$3.9M	﹤0.01%	2549
2016 Q3	$7.25M	Buy	314,491 +172,294	+121%	+$3.28M	﹤0.01%	2533
2016 Q2	$2.36M	Buy	142,197 +67,040	+89%	+$1.35M	﹤0.01%	2971
2016 Q1	$1.19M	Sell	75,157 -1,917	-2%	-$34.1K	﹤0.01%	3238
2015 Q4	$2.49M	Buy	77,074 +13,927	+22%	+$603K	﹤0.01%	3026
2015 Q3	$2.66M	Buy	+63,147	New	+$2.98M	﹤0.01%	3005

Other funds holding GBT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock Institutional Trust's GBT Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Global Blood Therapeutics, Inc. (GBT) stake by 71% in Q4 2016, buying an estimated $3.9M and bringing the position to 536,582 shares worth $7.75M. The position accounts for ﹤0.01% of the portfolio, ranked #2549.

BlackRock Institutional Trust first reported a position in GBT in Q3 2015 and has held it in 6 quarters since. 96 funds tracked by Wall St. Rank hold GBT as of Q4 2016.

BlackRock Institutional Trust held 536,582 shares of Global Blood Therapeutics, Inc. worth $7.75M as of Q4 2016.
BlackRock Institutional Trust bought 222,091 Global Blood Therapeutics, Inc. shares in Q4 2016, an estimated $3.9M.
Global Blood Therapeutics, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2549 holding.
BlackRock Institutional Trust first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and has held it in 6 quarters since.
96 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.